Fig. 5

Validation of SRlncRNA signature related to OS inGSE29609 cohort. A Survival analysis of low- and high-risk groups. B Heatmap of all samples. C Scatter plot about risk score, survival time and status. D ROC curves of the signature to predict 1-, 3- and 5-year survival. E Comparisons of the C-index between SRlncRNA signature and 99 previously published signatures in GSE29609 cohort